Toxicidad sistémica por anestésicos locales en paciente con hipoalbuminemia severa. Reporte de un caso / Case report Local anesthetic toxicity due to hypoalbuminemia

Local anesthetics are drugs widely used to perform peripheral nerve blocks. Signs and symptoms of toxicity may vary from mild to severe, including neuro and cardiotoxicity, with seizures and cardiac arrest. We present the case of an 85-year-old patient in total left knee replacement plan due to tibial saucer fracture, where systemic toxicity was observed by local anesthetics (LAST) after performing a femoral nerve block guided by neurostimulation and ultrasound with a solution of 20 ml of 0.525% ropivacaine + 0.6% lidocaine. As a positive data, the patient presented severe hypoalbuminemia

Los anestésicos locales son fármacos ampliamente utilizados para realizar bloqueos nerviosos periféricos. Los signos y síntomas de toxicidad pueden variar de leves a severos, incluidas la neuro y cardiotoxicidad, con convulsiones y paro cardíaco. Presentamos el caso de una paciente de 85 años de edad en plan de reemplazo total de rodilla izquierda debido a fractura de platillo tibial, donde se observó toxicidad sistémica por anestésicos locales (LAST por su sigla en inglés) después de realizar un bloqueo del nervio femoral guiado por neuroestimulación y ultrasonido con una solución de 20 ml de ropivacaína al 0,525% + lidocaína al 0,6%. Su único antecedente médico era presentar hipoalbuminemia severa.

Mortalidad en pacientes con enfermedad renal. Instituto de Nefrología. 2016 y 2017 / Mortality in patients with kidney disease. Institute of Nephrology, 2016 and 2017

Introducción: La Enfermedad Renal Crónica es un problema de salud mundial. Objetivo: Determinar el comportamiento de la mortalidad en pacientes con enfermedad renal en el Instituto de Nefrología durante 2016 y 2017. Material y Métodos: Estudio observacional descriptivo transversal de pacientes fallecidos con necropsia realizada. Se registraron variables demográficas, de laboratorio, las relacionadas con la terapia de reemplazo de la función renal y con el diagnóstico anatomo-patológico. Para cada una de las variables se calcularon frecuencias absolutas y relativas. En el caso de la variable presencia de sepsis en las defunciones, fue empleada la prueba de chi-cuadrado para la bondad del ajuste, para probar la hipótesis nula H0: de igualdad de la distribución de las tres categorías de la variable. Resultados: Se estudiaron 48 fallecidos con necropsia, 48,9 por ciento del total de fallecidos en el periodo. La correspondencia clínico patológica fue 80,1 por ciento. Predominó el sexo masculino, el grupo de edad superior a 60 años y la hipertensión arterial como antecedente. El método de terapia de reemplazo renal más documentado fue la hemodiálisis, mediante catéter venoso central un 87,8 por ciento. El 61,8 por ciento de los fallecidos recibieron tratamiento hemodialítico por 3 meses o menos. La sepsis fue la segunda causa de muerte precedida por eventos cardio y cerebrovasculares; no obstante, en el análisis de la totalidad de necropsias, la infección asociada directa o indirecta a la muerte tuvo una frecuencia mayor. Conclusiones: La infección directa o indirectamente asociada a la muerte, la hipoalbuminemia y el acceso vascular mediante catéter se relacionan con la mortalidad en el periodo(AU)

Introduction: Chronic kidney disease is a health problem worldwide. Objective: To determine the behavior of mortality in patients with kidney damage in the Nephrology Institute during the years between 2016 and 2017. Material and Method: A cross-sectional descriptive observational study was conducted in 48 deceased patients who underwent necropsy. Demographic and laboratory variables were recorded, as well as those related to the type of renal function replacement therapy and the anatomopathological diagnosis. Absolute and relative frequencies were calculated for each of the variables. In the case of the variable presence of sepsis in deaths, the Chi-Square Goodness-of-Fit Test was used to test the Null Hypothesis HO: uniformity of the distribution of the three categories of the variable. Results: A total of 48 deceased were studied at necropsy, representing 48.9 percent of the total number of deaths within the period. The clinical- pathological correlation was 80.1percent. The male sex, the group over the age of 60 years, and arterial hypertension as antecedent of the disease predominated in the study. The most documented method of renal function replacement therapy was hemodialysis which was performed through central venous catheter, 87.8 percent. The 61.8 percent of deceased patients received hemodialysis treatment for 3 months or less. Sepsis represented the second cause of death preceded by cardiovascular and cerebrovascular events. However, during the analysis of all the necropsies, the direct or indirect infection associated with the death had a greater frequency. Conclusions: Direct or indirect infections associated with death, hypoalbuminemia, and the vascular access with venous catheter was related to mortality during the observed period(AU)

Serum albumin level as a risk factor for mortality in burn patients

OBJECTIVE: Hypoalbuminemia is a common clinical deficiency in burn patients and is associated with complications related to increased extravascular fluid, including edema, abnormal healing, and susceptibility to sepsis. Some prognostic scales do not include biochemical parameters, whereas others consider them together with comorbidities. The purpose of this study was to determine whether serum albumin can predict mortality in burn patients. METHODS: We studied burn patients ≥16 years of age who had complete clinical documentation, including the Abbreviated Burn Severity Index, serum albumin, globulin, and lipids. Sensitivity and specificity analyses were performed to determine the cut-off level of albumin that predicts mortality. RESULTS: In our analysis of 486 patients, we found that mortality was higher for burns caused by flame (p = 0.000), full-thickness burns (p = 0.004), inhalation injuries (p = 0.000), burns affecting >30% of the body surface area (p = 0.001), and burns associated with infection (p = 0.008). Protein and lipid levels were lower in the patients who died (p<0.05). Albumin levels showed the highest sensitivity and specificity (84% and 83%, respectively), and the area under the receiver-operating characteristic curve (0.869) had a cut-off of 1.95 g/dL for mortality. CONCLUSION: Patients with albumin levels <2 g/dL had a mortality risk of >80%, with 84% sensitivity and 83% specificity. At admission, the albumin level could be used as a sensitive and specific marker of burn severity and an indicator of mortality. .

Hipoalbuminemia y tratamiento antineoplásico / Hypoalbuminemia and treatment antineoplastic

Introducción: Los pacientes oncológicos presentan deterioro nutricional aproximadamente del 40-80% los cuales pueden presentar bajos niveles de albumina en sangre (Hipoalbuminemia).Objetivo: Demostrar que la hipoalbuminemia puede constituirse como un factor pronóstico deaumento de toxicidad del tratamiento antineoplásico, evidenciando la necesidad de suplementoalimenticio o de administración de albumina parenteral previo al inicio del esquema quimioterápicoMetodología: Se tomaron al azar 101 pacientes con inicio de tratamiento antineoplásico sinimportar patología de base, se les midieron niveles de albúmina, y se tomaron laboratorios postquimioterapia durante las siguientes 24 a 48 horas. Por último se aplicó la escala de 1 a 5 sobreefectos adversos gastrointestinales y hematológicos del CTCAE (criterios y terminología comúnsobre efectos adversos).Resultados: La edad promedio del grupo fue de 45.8 años, con índice de feminidad de 1.3 a 1. Elnivel de albuminemia osciló entre 1.3 a 4.2 gr; y el 24.7% presentó signos y síntomas de toxicidad.La albuminemia en Leucemia Linfoide Aguda, no presentó variación significativa, pero sí lo fue en:Cáncer de Laringe, Mieloma Múltiple y Cáncer de Pulmón entre otros, exponiendo a los pacientes aefectos tóxicos. El Riesgo Relativo de presentar toxicidad por antineoplásicos fue 5.6 veces mayor enpacientes que tenían hipoalbuminemia, con intervalo de confianza de 3.4 a 9.27, chi2 de 50.44 yp<0.0001...

Introduction: Oncologic patients have nutritional deficit approximately in 40% - 80% of them, andthey can show low levels of serum albumin (hypoalbuminemia).Objective: Demonstrate that Hypoalbuminemia is a prognostic factor for toxicity for antineoplastictreatment.Methods: Randomly we included 101 patients who were receiving cancer treatment, with differenttypes of cancer (hematologic and solid), albumin was measured prior to initiation of therapy. On thebasis of the common criteria and terminology on adverse events, we apply a scale of 1-5 ongastrointestinal and hematologic adverse events.Results: The mean age was 45, 8 years, the woman: man rate was 1.3:1. The values of albuminwere from 1, 3 to 4, 2 gr., the 24, 7% showed signs and symptoms of toxicity. In Acute LinfoidLeukemia, was not frequent the alteration in the Albumin levels, nevertheless the albumin levelswere altered in larynx cancer, multiple mieloma, lung cancer, etc.. The adverse events weresignificantly more frequent in this last group (RR: 5.6; IC: 95%, 3, 4 - 9.27; chi: 50.44; p< 0.0001)...

Clinical Features and Predictive Factors of Acute Hepatitis A Complicated with Acute Kidney Injury / 대한소화기학회지

BACKGROUND/AIMS: We assessed the clinical features and prognosis of acute viral hepatitis A (AHA) complicated with acute kidney injury (AKI) and elucidated predictive factors for AKI in patients with AHA. METHODS: We reviewed medical record of 391 patients with AHA admitted at our institution since 2000. RESULTS: AKI was present in 45 patients (11.5%). The proportion of the AKI group increased since 2008 (5.4% before 2008 vs. 15.9% since 2008, p=0.001). The AKI group was older than the non-AKI group (35.7+/-8.7 years vs. 31.3+/-7.8 years, p=0.002). Other baseline clinical characteristics were similar between two groups. Initial hemoglobin, platelet, and serum albumin were significantly low and prothrombin time, serum bilirubin, creatinine, AST, and ALT were significantly high in the AKI group. Hepatic encephalopathy, ascites, gastrointestinal bleeding, and sepsis were more frequently observed in the AKI group. While six patients (13%) in the AKI group received liver transplantation (LT) but three patients died within one month, one patient in the non-AKI group receiving LT is alive. Multivariate analysis showed that older age (OR 1.07, 95% CI 1.02-1.12), initial thrombocytopenia <150,000/mm2 (OR 2.85, 95% CI 1.24-6.57), prothrombin time (PT) prolongation (OR 5.34, 95% CI 2.55-11.19), and hypoalbuminemia (OR 8.24, 95% CI 2.53-26.86) were independently associated with the occurrence of AKI. CONCLUSIONS: AHA with AKI is an increasing problem showing significant morbidity and mortality in Korea. AKI is highly associated with older age, initial thrombocytopenia, PT prolongation, or low serum albumin, and has bad prognostic effect.

Corticosteroid-responsive enteropathy of infancy.

Nineteen American infants aged less than three months developed persistent diarrhoea, acidosis, hypoalbuminaemia, and malnutrition, without evidence of enteric pathogens. Symptoms began 11-59 days before admission to the University of North Carolina Children's Hospital, and infants were fed semielemental formula. Despite further treatment with amino acid-based formula by continuous nasogastric infusion, diarrhoea persisted. Endoscopic biopsies showed inflammation in the stomach, duodenum, and/or colon. A trial of intravenous corticosteroids was initiated in 14 infants. Corticosteroids were associated with rapid resolution of diarrhoea (duration after corticosteroids = 3.8 +/- 1.7 days [mean +/- SD]). In contrast, five infants with identical history were not treated with corticosteroids. In three infants, diarrhoea lasted for 92-147 days versus 31 +/- 3 total days in the treated group. In the other two infants, diarrhoea worsened after discharge, but were treated later with corticosteroids, with rapid resolution. Corticosteroids were uneventfully weaned over a four-month period. The results suggest that a trial of corticosteroids in infants with unresponsive persistent diarrhoea of unknown origin is beneficial and deserves prospective evaluation.